Polycap for atherosclerosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 6 Nov 2017: Trial registered, NCT03329599
  2. 14 Feb 2019: Trial started, NCT03329599

The trials

NCT03329599: Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment

State
Completed
Phase
Phase 2
People
148 taking part
Started
14 Feb 2019
Primary completion
1 Dec 2021
Arms
Polypill
Results
Posted on the registry
  1. 6 Nov 2017: Trial registered
  2. 14 Feb 2019: Trial started
  3. 30 Mar 2022: Trial completed
  4. 20 Dec 2023: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.